Author ORCID Identifier
0000-0003-0705-1137
Abstract
In the last few decades, the growing use of telemedicine has allowed access to healthcare at reduced costs and increased monitoring of chronic conditions, especially in underserved and rural areas. It is a tool of great value in low-income countries where there is a paucity of specialists. In the height of the COVID-19 pandemic, telemedicine was used to screen patients with COVID-19 like symptoms and send them to test sites directly. This helped minimize unnecessary healthcare staff and patient exposure to the infection and helped decompress ERs. Due to a lack of testing resources, many mildly symptomatic patients were presumed to have COVID-19 infection and advised to self-isolate at home. We present a case of delayed diagnosis of acute leukemia resulting in a life-threatening presentation with leukostasis. This case highlights the need for a physical exam, lab investigations, and close follow-up for new patient complaints seen over telemedicine. It also highlights the lack of evidence for the efficacy and safety of telemedicine in patients with new complaints.
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Recommended Citation
Elkhapery A, Abbas S, Verghese B. Telemedicine, Not The Panacea We Thought It Would Be. A Tale Of Caution. Advances in Clinical Medical Research and Healthcare Delivery. 2023; 3(1). doi: 10.53785/2769-2779.1137.
Publisher Note
All articles published in ACMRHD are distributed with a Creative Commons CC BY-NC 4.0 license. Under this license, authors hold the copyright to their work and have the right to share or adapt the article with no restrictions, as long as the author(s) and source are cited, and the use is for noncommercial purposes. This policy went into effect November 1, 2023, and applies retroactively to all articles published in ACMRHD prior to that date, as well.